A 32-year-old woman with systemic lupus erythematosus (SLE) is started on mycophenolate mofetil (MMF) for lupus nephritis. After 6 weeks of therapy, she develops severe diarrhea and abdominal pain. Which investigation is most appropriate to assess for a potential serious adverse effect of MMF?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.